Beijing Continent Pharmaceutical Co, Ltd.

This study is testing whether pirfenidone capsules can help slow the progression of lung scarring in people with pneumoconiosis, a serious lung disease often caused by inhaling dust at work. The trial will involve 272 patients who will take either the drug or a placebo for 52 wee…

This is the first study in people to test a new oral drug called F230, which is being developed to treat pulmonary hypertension—a serious condition of high blood pressure in the lungs. The main goal is to check if the drug is safe and how it moves through the body in 136 healthy …

This study is testing a new drug called F573 for people with serious liver injury or failure. It aims to see if the drug is safe and can help control liver damage. About 97 participants will receive either the drug or a placebo injection daily for up to 28 days, along with standa…

This early-stage study is checking how a potential new drug for liver scarring is processed by the body and how safe it is for people with reduced kidney function. It will compare 56 participants, including healthy volunteers and people with mild to severe kidney problems, after …